Adia Nutrition, Inc. (ADIA) intrinsic value & 10-year financials

Adia Nutrition, Inc. (ADIA) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 3 fiscal years revenue grew 10879.8% a year to $700.5K, with an average return on invested capital of 1947.8%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$0.14
Market cap
$13.1M
Revenue (FY2025)
$700.5K
Revenue growth (3-yr CAGR)
10879.8%
ROIC (10-yr avg)
1947.8%
Free cash flow (FY2025)
-$192.4K

ADIA 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $700.5K -$395.5K $0.00 -$192.4K -52.3% 3978.2%
FY2024 $6.4K -$181.1K $0.00 -$357.3K -2739.0% -82.7%
FY2023 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Adia Nutrition, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Adia Nutrition, Inc. has historically struggled to out-earn its cost of capital, averaging just -21.5% ROIC.

Adia Nutrition, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Adia Nutrition, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.00 per share.

ADIA stock: frequently asked questions

What is the intrinsic value of Adia Nutrition, Inc. (ADIA) stock?

Graham's formula only works with positive earnings. Adia Nutrition, Inc. reported diluted EPS of $0.00 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Adia Nutrition, Inc. generate free cash flow?

Adia Nutrition, Inc. generated -$192.4K of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 2 reported years.

What is ADIA's return on invested capital?

Average ROIC over the last 3 fiscal years was 1947.8%, and average return on equity was -560.0%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ADIA data come from?

From Adia Nutrition, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 15, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medicinal chemicals & botanical products stocks